Drug Profile
INXC gTK
Latest Information Update: 02 May 2003
Price :
$50
*
At a glance
- Originator Inex Pharmaceuticals Corporation
- Class Antineoplastics; Gene therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer